Logiscreen

Haemonetics Corp

$71.28
Market Cap 3.31B
ROE 11.3%
Gross Margin 57.2%
Debt/Equity 1.5
Current Ratio 3.0
Revenue QoQ 4.8%
EPS QoQ -1.4%
F-Score 6

About

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components.

Exchange
NYSE
Sector
Healthcare
Industry
Medical Instruments & Supplies

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
33.36
vs median 33.61
P/B
4.08
vs median 2.16
ROE
0.11
vs median 0.09

Decent quality with acceptable fundamentals

Mid-cap company with growth potential

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics